Dr. Gregory K. Bell was appointed as a joint expert on behalf of both parties in a licensing dispute regarding a patented technology requiring royalty payments. Dr. Bell was asked to review the license and determine if the most favorable nation (“MFN”) clause had been violated by one party’s other licensing activity regarding the technology.
Anticompetitive conduct and patents listed in the Orange Book
Branded pharmaceutical manufacturers are required by law to list all patents in the Orange Book that cover an approved drug product. However,...